Your browser doesn't support javascript.
loading
Endocrine Conditions and COVID-19.
Shekhar, Skand; Wurth, Rachel; Kamilaris, Crystal D C; Eisenhofer, Graeme; Barrera, Francisco J; Hajdenberg, Michelle; Tonleu, Joselyne; Hall, Janet E; Schiffrin, Ernesto L; Porter, Forbes; Stratakis, Constantine A; Hannah-Shmouni, Fady.
Afiliação
  • Shekhar S; Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Wurth R; Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA.
  • Kamilaris CDC; Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Eisenhofer G; Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Barrera FJ; Institute of Clinical Chemistry and Laboratory Medicine, and Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Hajdenberg M; Endocrinology Division, Internal Medicine Department, University Hospital "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Tonleu J; Plataforma INVEST-KER Unit Mayo Clinic, School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Hall JE; College of Arts and Sciences at Washington University in St. Louis, Saint Louis, Missouri, USA.
  • Schiffrin EL; Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA.
  • Porter F; Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA.
  • Stratakis CA; Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Hannah-Shmouni F; Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
Horm Metab Res ; 52(7): 471-484, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32512611
ABSTRACT
COVID-19 was declared a global pandemic by the WHO and has affected millions of patients around the world. COVID-19 disproportionately affects persons with endocrine conditions, thus putting them at an increased risk for severe disease. We discuss the mechanisms that place persons with endocrine conditions at an additional risk for severe COVID-19 and review the evidence. We also suggest precautions and management of endocrine conditions in the setting of global curfews being imposed and offer practical tips for uninterrupted endocrine care.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Doenças do Sistema Endócrino Limite: Humans Idioma: En Revista: Horm Metab Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Doenças do Sistema Endócrino Limite: Humans Idioma: En Revista: Horm Metab Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos